Articles for Forbes are here.
Articles for Wharton Magazine are here
Entrepreneurship in Biotechnology at Columbia University is here
@dbsable on twittter is here
Video content is here
A graduate of the Wharton School and the University of Pennsylvania School of Medicine, David Sable served as resident and chief resident in obstetrics and gynecology at New York Presbyterian Hospital, followed by a fellowship in reproductive endocrinology at the Brigham and Women's Hospital in Boston, and moonlighting for the faculty practices at Harvard Medical School and MIT. He is board certified in both obstetrics and gynecology and reproductive endocrinology.
He served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, worked as a trader at Deutsche Bank, and currently is the life sciences portfolio manager for the Special Situations Funds. He founded Assisted Reproductive Medical Technologies (acquired by Saint Barnabas Medical Center), Innovation in Reproductive Medicine, and co-founded Reprogenetics (acquired by Cooper Surgical.) He has appeared on the CBS Morning News, ABC World News Tonight, and PBS' NOVA. In addition to his academic publications, he has written for the Newark Star-Ledger, Yoga Journal, Xconomy, Genetic Engineering and Biotechnology News, Wharton Magazine, the Columbia Spectator, and writes the “…and other secrets of the buy side” and the "...and other things I learned as an IVF doc" blogs for Forbes Magazine. He serves or has served on the boards of directors of Hamilton Thorne, GeneNews, the nonprofit organization Resolve, and on the clinical advisory boards for Ovascience and Progyny. An adjunct in the Department of Biological Sciences at Columbia University, he teaches Entrepreneurship in Biotechnology in the Graduate School of Arts and Sciences.